Innoviva (INVA) Net Cash Flow Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 198.34% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 467.41% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -14,223.53% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 453.08% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -125.22% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 53.46% |
| 10 | Innoviva | 1.60 Bn | 992.84 Mn | 75.83 Mn | 269.13% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 269.13% |
| Sep 30, 2025 | 155.60% |
| Jun 30, 2025 | 102.98% |
| Mar 31, 2025 | 193.20% |
| Sep 30, 2024 | 160.44% |
| Jun 30, 2024 | 33.37% |
| Mar 31, 2024 | 89.69% |
| Sep 30, 2023 | -211.83% |
| Jun 30, 2023 | -56.61% |
| Mar 31, 2023 | -1,062.23% |
| Sep 30, 2022 | 189.16% |
| Jun 30, 2022 | 127.87% |
| Mar 31, 2022 | -58.03% |
| Sep 30, 2021 | -268.63% |
| Jun 30, 2021 | -491.76% |
| Mar 31, 2021 | -50.73% |
| Dec 31, 2020 | -321.31% |
| Sep 30, 2020 | 113.09% |
| Jun 30, 2020 | -20.36% |
| Mar 31, 2020 | 2,602.45% |
| Dec 31, 2019 | 661.85% |
| Sep 30, 2019 | 180.27% |
| Jun 30, 2019 | 27.81% |
| Mar 31, 2019 | 105.92% |
| Dec 31, 2018 | 121.21% |
| Sep 30, 2018 | -458.07% |
| Jun 30, 2018 | 286.76% |
| Mar 31, 2018 | -210.54% |
| Dec 31, 2017 | -362.19% |
| Sep 30, 2017 | 154.59% |
| Jun 30, 2017 | 17.15% |
| Mar 31, 2017 | 664.60% |
| Dec 31, 2016 | -69.14% |
| Sep 30, 2016 | 72.12% |
| Jun 30, 2016 | -562.68% |
| Mar 31, 2016 | -116.68% |
| Dec 31, 2015 | 453.17% |
| Sep 30, 2015 | 19.94% |
| Jun 30, 2015 | -89.86% |
| Mar 31, 2015 | 343.41% |
| Dec 31, 2014 | 19.76% |
| Sep 30, 2014 | -223.49% |
| Jun 30, 2014 | 223.87% |
| Mar 31, 2014 | -110.65% |
| Dec 31, 2013 | -63.25% |
| Sep 30, 2013 | 44.02% |
| Jun 30, 2013 | -145.53% |
| Mar 31, 2013 | 661.97% |
| Dec 31, 2012 | 3.19% |
| Sep 30, 2012 | -74.99% |
| Jun 30, 2012 | 356.55% |
| Mar 31, 2012 | -97.09% |
| Dec 31, 2011 | -117.92% |
| Sep 30, 2011 | -321.78% |